Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations

Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations

ABSTRACTCancer patients are at risk for severe coronavirus disease 2019 (COVID-19) outcomes due to impaired immune responses. However, the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is inadequately characterized in this population. We hypothesized that...

Full description

Bibliographic Details
Main Authors: Elizabeth Titova, Veronica W. Kan, Tara Lozy, Andrew Ip, Kileen Shier, Vittal P. Prakash, Meghan Starolis, Sara Ansari, Kira Goldgirsh, Seoyeon Kim, Michael C. Pelliccia, Aamirah Mccutchen, Martinus Megalla, Thomas S. Gunning, Harvey W. Kaufman, William A. Meyer, David S. Perlin
Format: Article
Language:English
Published: American Society for Microbiology 2024-03-01
Series:Microbiology Spectrum
Subjects:
SARS-CoV-2
immune response
post-vaccination
immunocompromised
cancer
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02050-23

Internet

https://journals.asm.org/doi/10.1128/spectrum.02050-23

Similar Items